Delivery Order SPE2DB22D1017-SPE2DB24FE8TK
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $22,405.65 for the supply of Dupixent 300 mg/2 ml pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 28, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $11,267.53, is for the delivery of Dupixent 300 mg/2 ml pens. This is a firm fixed-price delivery order contract with an ultimate completion date of January 29, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products, including Dupixent 300 mg/2 ml pens. The contract, valued at $16,272.14, has a completion date of June 5, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,609.40 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of November 9, 2023. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award, with a ceiling value of $5,005.47, is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product. The contract has an ultimate completion date of April 29, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $25,808.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Dupixent 300 mg/2 ml pens, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 9, 2023 and is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $14,978.98 delivery order contract is for Dupixent 300 mg/2 ml pens and has a completion date of February 12, 2024. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB23FV37R) worth $8,215.42 for the supply of Dupixent 300 mg/2 ml pens. The contract is funded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 19, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,351.08 firm-fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens, a specialty medication, with a completion date of January 30, 2024. The contract has no set-aside requirements, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,966.99 firm fixed-price delivery order is for the supply of Dupixent 200 mg/1.14 ml pens. The contract has an ultimate completion date of October 25, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FE8TKDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Dupixent 300 mg/2 ml pens. The contract, valued at $13,785.81, is a firm fixed-price delivery order with a completion date of November 27, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 11/24/23 |